Nuvation Bio Announces Up to $250 Million Nondilutive Financings From Sagard Healthcare Partners
March 05, 2025
March 05, 2025
PALO ALTO, California, March 5 -- Cooley, a law firm, issued the following news release:
* * *
Nuvation Bio Announces up to $250 Million Nondilutive Financings From Sagard Healthcare Partners
San Francisco - March 3, 2025 - Cooley advised Nuvation Bio (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, on its nondilutive financings of up to $250 million with Sagard Healthcare Partners. The transaction comp . . .
* * *
Nuvation Bio Announces up to $250 Million Nondilutive Financings From Sagard Healthcare Partners
San Francisco - March 3, 2025 - Cooley advised Nuvation Bio (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, on its nondilutive financings of up to $250 million with Sagard Healthcare Partners. The transaction comp . . .